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The Evolution of Scholarship on the 
Cutting Edge
In the Fall of 2003, we devoted an issue of the Law & Health Care 
Program (L&HCP) newsletter to Scholarship on the Cutting Edge. In 
the introduction to that issue – which focused on the work of our fac-
ulty – we noted that “the field of health law offers a multitude of issues 
for thought-provoking scholarship ranging from whether or not to allow 
human cloning or whether to regulate IVF and genetic testing … to health 
insurance and fraud and abuse.” Over a decade later, these same issues 
continue to raise bedeviling and complex questions as science develops 
and the health care system evolves. As the L&HCP enters its 30th year 
of existence, cutting edge scholarship is still at the forefront of our pro-
gram. This pursuit is enhanced by the synergistic effect that having a 
critical mass of health law scholars in one place creates. As our faculty 
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has grown, so has the breadth of the health law topics we study. This has 
created valuable intersections that are reflected in our scholarship, teach-
ing, and in our clinics. For instance, scholarship by some of our faculty 
members relating to how medical marijuana should be regulated dovetails 
with the work of our drug policy and public health law clinics. Research 
on the use of “big data” in health care naturally implicates the work of 
our faculty members who focus on human subjects research and policies 
surrounding the use of genetic and other health information. Professors 
who focus on mental health law have collaborated with faculty who are 
focused on neuroscience and addiction to explore issues surrounding 
adolescent decision making for health care decisions. We also find many 
opportunities to work with the L&HCP’s affiliated scholarly centers (in-
cluding the Center for Health and Homeland Security and the Network for 
Public Health Law) as well as faculty members from the different profes-
sional schools on the University of Maryland campus. The L&HCP is 
more than the sum of its parts. Over time it has become a lively group of 
scholars who respond to and, equally as important, raise critical questions 
in health law that can often only be answered through a collaborative ap-
proach. This evolution over 30 years is reflected in the following update 
on the current work of L&HCP faculty members. 
 
Professor Diane Hoffmann
Professor Diane Hoffmann has directed the 
L&HCP at the Carey School of Law since 1999. 
Since joining the faculty, her scholarship has 
primarily followed two strands: one focusing on 
legal and ethical issues in end of life care and the 
treatment of pain; the second on the use and regula-
tion of new health-related technologies, products 
and procedures. These two areas of scholarship 
stemmed from joint appointments when she came 
to the law school—one with the campus Geriat-
rics and Gerontology Education and Research 
(GGEAR) Program, the other with the University’s 
Program on Public Issues in Biotechnology, which, at the time, was a 
program of the Maryland Biotechnology Institute.
Over the last decade her earlier focus on end of life care evolved into a 
focus on legal obstacles to the treatment of pain and arguments for more 
rational laws and enforcement of laws related to physician prescribing of 
opioids, see e.g. “Treating Pain v. Reducing Drug Diversion and Abuse: 
Recalibrating the Balance in Our Drug Control Laws & Policies,” 1 St. 
Louis University Journal of Health Care Law and Policy 231 (2008). 
Her numerous articles on this topic led her to write a “Perspective” piece 
for the New England Journal of Medicine on medical marijuana and the 
law—both opioids and marijuana are scheduled substances under the 
Controlled Substances Act. In that piece, co-authored with Prof. Ellen 
Weber, the authors argued that moving marijuana from a Schedule I to 
a Schedule II substance would allow for a more rational approach to 
Prof. Diane Hoffmann
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advancing effective cannabinoid based medical treat-
ment. As a result of the article, Hoffmann has given 
numerous talks at conferences around the country on 
the legal issues associated with state medical mari-
juana laws and continues to follow the growing state 
legislation on this topic.
Consistent with the second strand of her research, in 
2009 Hoffmann received a three year grant from the 
NIH under the ethical, legal and social issues (ELSI) 
program of the Human Microbiome Project (HMP).  
The grant was awarded to Hoffmann, who was the 
Principal Investigator on the project, along with co-
investigators at Maryland’s schools of law, medicine 
and pharmacy, to examine the current regulation of 
probiotics, i.e., substances containing live microorgan-
isms that have a beneficial effect when taken in suffi-
cient quantities by manipulating microbiome and host 
properties.  Hoffmann formed a working group of sci-
entists doing research on the human microbiome, food 
and drug law attorneys, health law professors, industry 
representatives, consumer advocates, and regulators 
from the Federal Trade Commission and the Cana-
dian Health Products Directorate, to examine whether  
the current U.S. regulatory framework for probiotics 
adequately addresses issues of safety and effective-
ness, provides sufficient information to consumers to 
make informed choices about probiotic products, and 
does not discourage research on potential therapeutic 
benefits of these  products.  The project resulted in 
a White Paper and articles in Science (“Probiotics: 
Finding the Right Regulatory Balance,” Oct. 2013), 
Beneficial Microbes (“Health Claim Regulation in the 
EU and the US: Which is the Better Approach,” 2013) 
and the Journal of Food & Drug Law (“Probiotics: 
Achieving a Better Regulatory Fit,” 2014). Hoffmann 
is also working, with colleague Jack Schwartz, on a 
fourth article resulting from this project on establish-
ing a modified private right of action under the Federal 
Trade Commission Act for false or unsubstantiated 
health claims.  
The ELSI project also led Hoffmann to co-author 
(with Dennis Fortenberry MD, MS and Jacques Ravel, 
PhD) another article about legal and ethical issues in 
human subject research generated by the HMP. The 
article was part of a special volume of the Journal of 
Law, Medicine & Ethics, guest edited by Carey Law 
Professor Leslie Meltzer Henry, on proposed changes 
to the federal Common Rule for conducting research 
on human subjects. In the piece, “Are Changes to the 
Common Rule Necessary to Address Evolving Areas 
of Research? A Case Study Focusing on the Human 
Microbiome Project,” Hoffmann and her co-authors 
explore ways in which research conducted under the 
HMP, like research conducted under the Human Ge-
nome Project, raises challenging issues for regulation 
of human subjects research, particularly issues related 
to subject selection and recruitment, group stigma, and 
information risks. She will be speaking on this topic 
at an upcoming meeting of the Institute of Medicine.  
Next on Hoffmann’s research list is an examination 
of the potential regulatory frameworks for microbiota 
transplants. 
 
Professor Richard Boldt
Professor Richard Boldt has 
been on the University of Mary-
land faculty since 1989. He 
teaches and writes in the areas 
of constitutional law, criminal 
law, mental disability law and 
torts and has a special research 
interest in legal issues surround-
ing mental health and drug use 
disorders. Professor Boldt has 
three recent articles, including 
two coming out in the next few 
months, which reflect his deep interest in these areas 
from both a research and advocacy perspective. 
The first paper, “The ‘Voluntary’ Inpatient Treatment 
of Adults Under Guardianship,” which will appear 
in Volume 60, Issue 1 of the Villanova Law Review, 
tackles a gap in the laws that relate to hospitalization 
of adults under guardianship.  Boldt’s interest in the 
issue was generated by an inquiry from a practitioner 
in Washington, DC and subsequently developed into 
Since joining the faculty, Professor 
Hoffmann's scholarship has primarily 
followed two strands: one focusing on legal 
and ethical issues in end of life care and 
the treatment of pain; the second on the 
use and regulation of new health-related 
technologies, products and procedures.
Prof. Richard Boldt
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a full blown research project when Boldt realized that 
the answer was not only complicated but variable 
across states and jurisdictions.  A number of states 
have adopted a preference for voluntary hospitaliza-
tion over involuntary civil commitment for adults with 
severe mental illness who require inpatient treatment.  
Frequently, however, the disabilities that call for 
inpatient treatment also disrupt an individual patient’s 
capacity to participate fully in the decision-making 
process by which hospital admission is elected.  The 
appointment of a guardian for some of these patients 
could provide a solution to this problem, but a range 
of statutory and case law limitations complicate mat-
ters.  Boldt’s article provides a brief history of the 
law in this area, explores the role that informed con-
sent plays in voluntary hospitalizations, provides an 
analysis of the interests in tension when a guardian 
is appointed, and offers a framework for an effec-
tive statutory approach that would allow guardians to 
arrange for voluntary hospitalization of a ward  if the 
substantive standards and procedural requirements put 
in place by state law are adequate to insure that third-
party decision-makers are acting with respect for the 
values held by these patients and, to the extent pos-
sible, are seeking to serve their best interests.
In Boldt's recent article in the Maryland Law Review 
about problem-solving courts, he steps back from the 
mechanics of such courts to conclude that the practice 
is—to date—undertheorized and to urge that pragma-
tist theory be employed to guide the development of 
these courts.
In an article on a related theme, “Perspectives on 
Outpatient Commitment,” which will appear in Vol-
ume 49, Issue 1 of the New England Law Review, 
Boldt discusses research that he began as part of an 
initiative that he worked on with L&HCP Professors 
Diane Hoffmann and Amanda Pustilnik regarding 
outpatient civil commitment, also known as “as-
sisted outpatient treatment” (AOT) or “mandatory 
outpatient treatment.” The initiative was convened to 
discuss whether stakeholders in Maryland might be 
able to reach consensus on a path to improving access 
to outpatient mental health care in Maryland. As part 
of this initiative, Professor Boldt studied legislative 
approaches to outpatient commitment. Boldt’s most 
recent article on the issue discusses proposed legisla-
tion at the federal level, including a bill introduced in 
the fall of 2013 by U.S. Representative Tim Murphy 
entitled the “Helping Families in Mental Health Crisis 
Act of 2013,” which was fashioned to reform a num-
ber of existing policies and practices and included 
a controversial provision designed to encourage the 
states to make greater use of outpatient civil commit-
ment. The Murphy reform bill was met in the House 
of Representatives by an alternative set of proposals 
developed by Representative Ron Barber to increase 
funding for community-based treatment. The Barber 
bill did not include provisions to encourage the use 
of outpatient commitment or other forms of enforced 
community-based care. Boldt’s article provides a brief 
history of the law governing involuntary civil com-
mitment in the United States and reviews the avail-
able data on the outcomes of involuntary outpatient 
treatment, particularly with respect to subsequent 
hospitalizations and criminal system involvement, and 
concludes with a summary assessment of the consider-
ations pushing for and against the greater adoption of 
outpatient commitment.
 
Professor Michael Greenberger
Professor Greenberger is the 
Director of the University of 
Maryland Center for Health and 
Homeland Security (CHHS), 
an academic and non-profit 
consulting entity with over 60 
professionals on staff working 
on over 90 contracts world-
wide. Among CHHS’ key areas 
of expertise are public health 
emergency preparedness and re-
sponse, medical surge planning, 
mass fatality planning, training 
Prof. Michael 
Greenberger
In Boldt's recent article in the Maryland Law 
Review about problem-solving courts, he 
steps back from the mechanics of such courts 
to conclude that the practice is—to date—
undertheorized and to urge that pragmatist 
theory be employed to guide the development 
of these courts. 
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and exercises, interoperability, cybersecurity, continu-
ity of government, continuity of operations, critical 
infrastructure protection, and energy resilience. (More 
information about CHHS can be found at www.umary-
land.edu/healthsecurity/ and at www.mdchhs.com.)
Over the past year, Professor Greenberger has spo-
ken on a number of issues related to biosecurity and 
dual use of research of concern. This research may 
provide knowledge, information, products, or tech-
nologies that could be directly misapplied to pose a 
significant threat with broad potential consequences to 
public health and safety and national security. Earlier 
this year Greenberger spoke on this topic as a panel-
ist at an AALS session entitled, “Risk and Regula-
tion: Biosecurity and the Law.” In February, Professor 
Greenberger led CHHS’ efforts to coordinate with 
the Middle Atlantic Regional Center of Excellence 
for Biodefense and Emerging Infectious Diseases 
(MARCE) to host a conference on “Laboratory and 
Public Safety Preparedness for Dual Use Research of 
Concern.” The MARCE Conference brought profes-
sionals from emergency management, public health, 
the legal community, and federal, state and local 
governments together to address how to properly 
balance the ability to conduct biological research on 
potentially lethal pathogens with the implementation 
of appropriate protective biosafety mechanisms to 
prevent against the accidental or intentional release of 
such pathogens.
Professor Greenberger currently serves by appoint-
ment of the Governor of Maryland on the Commission 
on Maryland Cybersecurity Innovation and Excellence 
and is a member of the Baltimore Washington Cyber 
Task Force. Additionally, he was recently appointed 
to serve on the Editorial Board for the Disaster and 
Military Medicine journal; on the Committee on Sci-
ence, Technology, and Law at the National Academy 
of Sciences; and previously served as the Chair of the 
Maryland Governor’s Emergency Management Advi-
sory Council. 
Recognized as a national expert in a number of 
areas, Professor Greenberger is called upon frequently 
to provide analysis and commentary on issues such 
as domestic and international responses to naturally-
occurring and man-made emergencies; biosecurity 
and laboratory safety; counterterrorism strategies; and 
cybersecurity law and policy.
Professor Leslie Meltzer Henry
Professor Leslie Meltzer Henry joined the law 
school faculty in 2008. In ad-
dition to teaching at the law 
school, she is a faculty member 
at the Johns Hopkins Berman 
Institute of Bioethics. The focus 
of Professor Henry’s teaching 
and scholarship is constitutional 
law, bioethics, public health law 
and policy, reproductive justice, 
and research ethics.
Professor Henry is work-
ing with colleagues at Johns 
Hopkins on a project about the 
concept of dignity in law and medicine. The project, 
funded by a grant from the Gordon and Betty Moore 
Foundation, is designed to study and make recom-
mendations regarding the loss of dignity that patients 
may experience in intensive care units (ICU). The first 
phase of the grant came to a close this summer. Henry 
was the team lead for the component of the grant that 
involved conceptualizing the meaning of dignity in 
the ICU. Based on the conceptual model the team 
created, Henry co-wrote an article entitled, “Respect 
and Dignity: A Conceptual Model for Patients in the 
ICU,” in Narrative Inquiry in Bioethics (forthcoming 
2014). The article notes that, although the concept of 
dignity is commonly invoked in clinical care, there is 
not widespread agreement—in either the academic lit-
erature or in every-day clinical conversations—about 
what dignity means. This makes it difficult to deter-
mine what threatens patients’ dignity and, conversely, 
how to honor commitments to protect and promote 
Prof. Leslie Meltzer 
Henry
Professor Greenberger has spoken on a 
number of issues related to biosecurity 
and "dual use of research of concern." 
This research may provide knowledge, 
information, products, or technologies 
that could be directly misapplied to pose 
a significant threat with broad potential 
consequences to public health and safety and 
national security. 
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it. The article presents the first conceptual model of 
dignity for patients in the ICU based on the notion 
that there are three sources of patients’ dignity—their 
shared humanity, personal narratives, and autono-
my—each of which independently warrants respect. 
The article describes each source of dignity and draws 
on examples to illustrate how clinician attitudes, ac-
tions, and behaviors can either contribute to, or detract 
from, expressions of respect for patient dignity.
Professor Henry is also continuing her work on ethi-
cal and legal protections for human research subjects. 
Last summer, she edited a symposium issue of The 
Journal of Law, Medicine & Ethics entitled “Revising 
the Common Rule: Prospects and Challenges.” This 
symposium issue of the journal grew out of a round-
table the L&HCP sponsored with the Berman Institute 
to address an Advance Notice of Proposed Rulemak-
ing (ANPRM) that was circulated for comment to 
every federal agency regarding updates to the Com-
mon Rule – the regulations governing use of human 
subjects in government-funded research. In addition 
to discussing the topic areas identified in the ANPRM 
as focal points for change, participants also considered 
mechanisms for enhancing research protections that 
might require amending the Common Rule beyond the 
ANPRM’s proposals. The conversations and presenta-
tions at the Roundtable resulted in seven papers in the 
symposium issue of the journal. Henry wrote an article 
published in that issue about why the United States 
has not developed a no-fault compensation system for 
injured research subjects. That article is called “Moral 
Gridlock: Conceptual Barriers to No-Fault Compensa-
tion for Injured Research Subjects.” In relation to this 
scholarship, Professor Henry has made presentations 
to the staff of the Presidential Commission for the 
Study of Bioethical Issues, at the Health Law Profes-
sors’ Conference, and the Johns Hopkins Berman 
Institute of Bioethics Seminar Series.
On another front, Professor Henry is a team member 
on an NIH-funded grant entitled “PHASES—Pregnan-
cy and HIV/AIDS: Seeking Equity Study.” The project 
aims to understand and remedy the underinclusion of 
pregnant women, women of childbearing potential, 
and women who are lactating from HIV/AIDS clini-
cal trials. Stemming from this initiative is an article 
she is co-authoring with the team that explores how 
the current legal and regulatory framework for human 
subjects research may contribute to the underinclusion 
of women. The research team is holding a meeting in 
November with legal stakeholders (general counsels 
from the pharmaceutical industry and major research 
institutions, former FDA regulators, and food and drug 
lawyers) in this area to inform the team’s work. 
In a different but related vein, Professor Henry has 
been doing some writing about the ethical and legal 
aspects of the Facebook Study that was recently in the 
news. Facebook generated anger among some mem-
bers of its social network after a study was published 
based on manipulations of its users' news feeds. The 
study involved altering the news feeds of roughly 
689,000 users to determine whether positive or nega-
tive content would affect their emotions and subse-
quent Facebook updates. Henry was quoted in the 
Wall Street Journal and ABCNews.com commenting 
on the study, and with UM Carey Law faculty member 
James Grimmelman, she co-authored several impact 
letters to the involved parties that aim to improve re-
search protections for consumers of social media.  
Professor Kathleen Hoke
Professor Kathleen Hoke directs the Legal Resource 
Center for Public Health 
Policy, funded by the Mary-
land Department of Health 
and Mental Hygiene, and the 
Network for Public Health 
Law’s Eastern Region, funded 
by the Robert Wood Johnson 
Foundation. Hoke teaches 
the Public Health Law Clinic 
through which she engages 
law students in the work of the Prof. Kathleen Hoke
Professor Henry is working with colleagues 
at Johns Hopkins on a project about the 
concept of dignity in law and medicine. The 
project, funded by a grant from the Gordon 
and Betty Moore Foundation, is designed 
to study and make recommendations 
regarding the loss of dignity that patients may 
experience in intensive care units. 
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journals, including articles on hookah smoking pub-
lished in the American Journal of Public Health and 
in Nicotine and Tobacco Research and on cigar pack-
aging published in Progress in Community Health 
Partnerships: Research, Education, and Action.
Professor Frank Pasquale
Professor Frank Pasquale joined the Law & Health 
Care Program in 2013 and teaches Administrative 
Law, Health Care Law and 
Policy, and the Health Infor-
mation Privacy and Innova-
tion seminar. These courses, 
as well as numerous note and 
comment supervisions, allow 
Pasquale to share his deep 
interest and background in 
information law with our stu-
dents. In classes and research, 
they explore how technol-
ogy is changing the role and 
impact of information in our 
lives. 
While Pasquale's past legal scholarship has explored 
ways of advancing the use of technology in health 
care, his new book The Black Box Society explains 
how principles of health care policy should inform 
internet regulation. For example, Pasquale argues 
that consumers should be able to access all data held 
about them, not just health data, because health status 
can be inferred from data not covered under HIPAA. 
The book was cited in the White House Report on Big 
Data, and Pasquale will be giving book talks at Yale, 
Hoke has authored legal synopses published 
by the Tobacco Control Legal Consortium, 
including "Regulating Tobacco Advertising 
and Promotion: A ‘Commerce Clause’ 
Overview for State and Local Governments," 
and filed petitions with the Food and Drug 
Administration requesting the agency take a 
more flexible approach to regulating nicotine 
replacement therapy and to expanding 
regulatory power over cigars. 
Network and the Center. 
Through the Legal Resource Center (LRC) (www.
law.umaryland.edu/programs/publichealth), Hoke 
provides technical legal assistance to Maryland state 
and local health officials, legislators, and organiza-
tions working in tobacco control, obesity reduction, 
and injury prevention. Recent work has focused on 
the regulation of cigars and electronic cigarettes, 
the development of sound policies to create smoke-
free multiunit housing, legislation to prevent injury 
by requiring seatbelts for all vehicle occupants, and 
legislative mandates that childcare facilities serve only 
healthy beverages. 
The Network for Public Health Law (www.net-
workforphl.org) provides technical legal assistance 
to national, state and local public health profession-
als, their attorneys, legislators, researchers, and ad-
vocates working to develop sound public policy to 
improve public health. This assistance often results 
in the creation of fact sheets, issue briefs, 50-state 
surveys, webinars, and other useful tools on emerg-
ing and persistent public health issues. Under Hoke’s 
direction, the Network’s Eastern Region deliverables 
have focused on environmental health, food safety and 
injury prevention. 
In addition to contributing to, and supervising LRC 
and Network products, Hoke writes about emerging 
issues in tobacco regulation. Hoke has authored legal 
synopses published by the Tobacco Control Legal 
Consortium, including Regulating Tobacco Advertis-
ing and Promotion: A ‘Commerce Clause’ Overview 
for State and Local Governments, and filed petitions 
with the Food and Drug Administration requesting 
the agency take a more flexible approach to regulat-
ing nicotine replacement therapy and to expanding 
regulatory power over cigars. Professor Hoke has also 
filed amicus curiae briefs with the Supreme Court in 
two tobacco cases, Rowe v. New Hampshire Motor 
Transport (cited in Justice Ginsburg’s concurrence) 
and Altria v. Good. In 2011, Hoke co-authored an 
op-ed piece for the Jurist Forum, commenting on the 
Supreme Court’s First Amendment case, Sorrell v. 
IMS Health. Recently she co-authored an op-ed piece 
for the National Law Journal on the $23 billion jury 
verdict in Johnson v. R.J. Reynolds, a civil case in 
Florida. 
Hoke also engages in interdisciplinary collaboration 
which has resulted in publications in social science 
Prof. Frank Pasquale
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SUNY-Buffalo, the University of Virginia, and several 
other institutions. 
In addition to his new book, Pasquale addressed data 
policy in the health care industry in several venues 
over the summer. In June, Pasquale and Professor Me-
lissa M. Goldstein of George Washington University’s 
School of Public Health presented a report on a panel 
titled “Exploring Legal Challenges to Fulfilling the 
Potential of mHealth in a Safe and Responsible Envi-
ronment,” to members of the American Association for 
the Advancement of Science (AAAS) Working Group 
on mHealth (the use of mobile communications in 
health care). The panel focused on regulation, guide-
lines, and policies relating to mHealth which raise 
questions about the type of regulatory framework that 
will both facilitate innovation and deployment of new 
technologies, and protect patients.
Professor Pasquale also presented on data policy at 
the Health Privacy Summit at Georgetown Law Center 
in June. The Summit brought together national and in-
ternational privacy experts from academia, along with 
healthcare providers, information technology special-
ists, industry representatives, and government officials 
to hear insights, ideas, and analysis from leaders in 
the health privacy community. The Summit focused 
on patient identification issues, mobile application 
privacy, international cybersecurity, and research data. 
Pasquale spoke on a panel titled “Privacy, Big Data, 
and Mobile: Technologies Operating Outside HIPAA 
Protection.”
In addition to these projects, Pasquale was appointed 
to a University of Maryland committee exploring 
the ethical, legal, and social implications of big data 
research. He has also joined the Council for Big Data, 
Ethics, and Society, a national committee of aca-
demics in data science, law, informatics, and social 
science, supported through a grant by the National 
Science Foundation as part of the National Big Data 
Initiative. The Council meets four times a year and 
publishes reports in order to help researchers, practi-
tioners, and the public understand the social, ethical, 
and legal issues that underpin the "big data" phenom-
enon.
In addition to his work in the area of big data, Pro-
fessor Pasquale has written and presented on other 
topics. His article “Private Certifiers and Deputies 
in American Health Care” was recently published in 
the North Carolina Law Review. At the Privacy Law 
Scholars Conference in June, Pasquale and UM Carey 
Law Professor Danielle Citron’s paper “The Scored 
Society: Due Process for Automated Predictions,” was 
selected out of the over 60 papers presented for an 
award from the International Association of Privacy 
Professionals for “overall excellence and relevance to 
the profession of privacy.” Another Pasquale proposal 
on automation and the professions was selected by Tri-
ple Canopy, an arts and culture organization based in 
New York, as one of seven commissions chosen from 
over 350 applications in 2014. The paper includes 
sections on legal and medical automation. Pasquale 
published an early draft version of part of the paper as 
a blog post, which was praised by the President of the 
American Association of Law Schools (Dan Rodri-
guez) as “an extraordinarily thoughtful, informed per-
spective on the ‘machine v. lawyers’ ” debate. 
Professor Amanda Pustilnik
Amanda C. Pustilnik is an Associate Professor of 
Law at the University of Maryland School of Law, 
where she teaches Criminal 
Law, Evidence, and Law & 
Neuroscience. Her current re-
search includes work on mod-
els of mind in criminal law, 
evidentiary issues presented by 
neuroscientific work on mem-
ory, and how neuroscience can 
help the law reconceptualize its 
approaches to questions involv-
ing physical and emotional 
While Pasquale's past legal scholarship has 
explored ways of advancing the use of tech-
nology in health care, his new book The 
Black Box Society explains how principles 
of health care policy should inform internet 
regulation. For example, Pasquale argues 
that consumers should be able to access all 
data held about them, not just health data, 
because health status can be inferred from 
data not covered under HIPAA. Prof. Amanda Pustilnik
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pain in legal domains ranging from tort to torture. 
As part of her ongoing scholarship in the area of 
neuroscience and the law, in April of this year, Profes-
sor Pustilnik organized two L&HCP events. The first 
event was the L&HCP’s annual Rome Lecture which 
was given this year by Stanford Law Professor Hank 
Greely on the topic of “Neuroimaging, Mindreading, 
and the Courts.” Professor Greely’s talk was a kick 
off to the interdisciplinary roundtable that took place 
the following day on the topic of “Imaging Brains, 
Changing Minds: Chronic Pain Neuroimaging and 
the Law.” The roundtable was designed to create a 
dialogue between the fields of law and neuroscience 
and to make legal actors aware of recent breakthrough 
work in neuroimaging that has led to a paradigm shift 
in understanding chronic pain.  Professor Pustilnik 
look at questions that arise as science, law, finance and 
public policy intersect such as whether brain imaging 
can distinguish truth from falsehood or predict who 
will become violent and determine how to prevent 
it. The Center addresses these issues by monitoring 
relevant brain discoveries; promoting neuroscience 
that is responsible, ethical and scientifically sound; and 
discouraging premature or inappropriate use of scien-
tific findings.
Professor Karen Rothenberg
Professor Karen Rothenberg, the founding director 
of the L&HCP, is currently on leave from the L&HCP, 
serving as Senior Advisor on Genomics and Society 
to the Director of the National 
Human Genome Research In-
stitute (NHGRI) and a visiting 
scholar at the National Insti-
tutes of Health Department of 
Bioethics. 
As we noted in the Spring 
2014 edition of the L&HCP 
newsletter, in addition to her 
work on a variety of ge-
netic policy issues, Professor 
Rothenberg’s current research 
focuses on the use of theatre 
as an innovative tool to identify and encourage dis-
cussion of the unique ethical, legal and social issues 
posed by emerging technologies in health care. This 
year, Rothenberg and her colleague Dr. Lynn Bush 
of Columbia University Medical Center, published a 
book, The Drama of DNA: Narrative Genomics. The 
book uses excerpts from Rothenberg and Bush’s origi-
nal plays and plays by other authors to examine the 
implications of genomic technologies in today’s soci-
In April, Rothenberg moderated a discussion 
at the Smithsonian in Washington, DC 
with several contemporary playwrights who 
have used theatre to examine the ethical, 
legal, and social issues that genomics have 
introduced into our lives, as well as to 
stimulate conversations about biomedical 
research. 
Prof. Karen Rothenberg
During the Spring 2015 semester, Professor 
Pustilnik will serve as the first Senior Fellow 
in Law and Neuroscience at the Center for 
Law, Brain & Behavior at Massachusetts 
General. As a Fellow, Pustilnik will pursue 
original research, mentoring, and public 
engagement related to issues of pain and the 
law. 
organized and moderated the roundtable in collabo-
ration with Dr. David Seminowicz from the Depart-
ment of Neural and Pain Sciences at the University of 
Maryland School of Dentistry, and with the support 
of the American Association for the Advancement of 
Science’s Scientific Responsibility, Human Rights and 
Law Program. Prominent legal academics, scientists 
and judges attended the roundtable. Pustilnik is cur-
rently working with several of the participants in the 
roundtable on articles that will appear in an upcoming 
symposium issue of the L&HCP’s Journal of Health 
Care Law & Policy next year.
During the Spring 2015 semester, Professor Pustilnik 
will serve as the first Senior Fellow in Law and Neu-
roscience at the Center for Law, Brain & Behavior at 
Massachusetts General. As a Fellow, Pustilnik will pur-
sue original research, mentoring, and public engage-
ment related to issues of pain and the law. The Center 
is a collaboration between Massachusetts General 
Hospital and Harvard Law School and was created to 
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ety as well as to foster a greater understanding of how 
genomic information should be evaluated, processed, 
and shared. The book links readers to online versions 
of their original plays and is designed to serve as a 
resource to health care providers, researchers, patients, 
and their families. 
Rothenberg’s collaboration with Dr. Bush, which be-
gan when Rothenberg spent academic year 2009-2010 
on sabbatical as a Scholar-in-Residence at Columbia 
Law School, has been a fruitful one. They have co-
authored many short plays to help convey the com-
plexity of ethical issues raised by genomic research. 
Their plays were presented at an Ethical, Legal, and 
Social Issues (ELSI) Congress sponsored by NHGRI 
and have been performed by interdisciplinary groups 
of professionals in Australia, the Netherlands, and 
London and at the annual meetings of the American 
Society of Human Genetics, the American Society for 
Bioethics and Humanities, National Society of Genetic 
Counselors, Public Responsibility in Medicine and 
Research (PRIM&R), and several institutes within 
NIH. Recently Rothenberg engaged the staff of the 
Presidential Commission for the Study of Bioethical 
Issues in reading one of the plays aloud. 
In April, Rothenberg moderated a discussion at the 
Smithsonian in Washington, DC with several contem-
porary playwrights who have used theatre to examine 
the ethical, legal, and social issues that genomics 
have introduced into our lives, as well as to stimulate 
conversations about biomedical research. Playwrights 
Dorothy Fortenberry (The Good Egg), Lisa Loomer 
(Distracted), Cassandra Medley (Relativity), and Anna 
Ziegler (Photograph 51) discussed why and how they 
used complex topics rooted in genetics —including is-
sues of identity, the power of genetic information, and 
the impact of health decisions on family dynamics—in 
their work. The program was designed to complement 
the National Museum of Natural History exhibition 
“Genome: Unlocking Life's Code,” which is co-spon-
sored by NHGRI and for which Rothenberg was asked 
to conduct public outreach. Rothenberg is planning 
future programs in conjunction with the exhibit which 
will travel to science museums around the country and 
Canada over the next few years. 
In addition to her theatre-related work, Rothenberg 
recently co-authored a paper in the Georgetown Law 
Journal titled “Finding Fault? Exploring Legal Duties 
to Return Incidental Findings in Genomics Research,” 
which deals with the issue of incidental findings that 
come up when the whole genome of an individual is 
sequenced.
Professor Ellen Weber 
Professor Ellen Weber created and teaches the Drug 
Policy and Public Health Strategies Clinic in which 
she and her clinic students focus on policy develop-
ment to expand access to sub-
stance use treatment services 
and represent clients who face 
discrimination based on their 
history of drug dependence. 
Over the past four years, Weber 
has focused her clinic work and 
scholarship on the implementa-
tion of the Affordable Care Act 
in Maryland and the Mental 
Health Parity and Addiction Eq-
uity Act. The Clinic has received 
two multi-year grants from the Open Society Founda-
tion to support this work with the goal of ensuring that 
Maryland’s consumers benefit from the significant 
expansion of drug treatment services under the ACA. 
 One component of Weber’s health care reform 
implementation projects grew out of her 2013 article 
on the Parity Act, “Equality Standards for Health 
Insurance Coverage: Will the Mental Health Parity 
and Addiction Equity Act End the Discrimination,” 
published in the Golden Gate University Law Review. 
The article explored the Parity Act’s expansive non-
discrimination standards which, according to Weber, 
could address many of the health plan design features 
that have historically limited access to substance use 
and mental health treatment through private insurance. 
Prof. Ellen Weber
Looking ahead to the second year of ACA 
implementation, Professor Weber and her 
Clinic students will help develop strategies 
to ensure that persons entering and leaving 
local jails are enrolled in health insurance 
plans and that individuals maintain 
insurance coverage and have effective appeal 
rights.
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In the article, Weber recommended strategies that 
would ensure more effective enforcement of the Parity 
Act by state insurance departments. 
Weber has tested her recommendations for achiev-
ing enforcement of the Parity Act in Maryland through 
her clinic practice. Over the past three years, Weber’s 
students have advocated for legislation in the Mary-
land General Assembly that would require insurance 
carriers to report key data points to the state insurance 
administration to facilitate the State’s review of plans 
for parity compliance. This would address one of the 
key barriers to consumer enforcement of the Parity 
Act. Most recently, Weber’s clinic students investi-
gated whether the roughly eighty individual health 
plans offered in 2014 through Maryland’s marketplace 
complied with the Parity Act. The students identified 
significant gaps in the carriers’ assessment of plan 
features for parity compliance and the State’s review 
of plan compliance. As a result of this work, the Clinic 
has asked the Centers for Medicare and Medicaid 
to intervene to ensure that the State’s 2015 health 
plans meet the ACA’s standards for mental health and 
substance use benefits. Weber and her students have 
also provided extensive community education about 
the expanded drug and mental health treatment that is 
available under the ACA and have compiled a set of 
“Frequently Asked Questions” that responds to provid-
er and consumer questions about those services under 
private and public insurance. Looking ahead to the 
second year of ACA implementation, Professor Weber 
and her Clinic students will help develop strategies to 
ensure that persons entering and leaving local jails are 
enrolled in health insurance plans and that individuals 
maintain insurance coverage and have effective appeal 
rights. Weber plans to address the lessons she is learn-
ing through the Clinic’s ACA implementation work in 
her future scholarship. 
In relation to her work, Weber has given several 
recent presentations recently to the Tuerk Conference 
(sponsored by the National Council on Alcoholism and 
Drug Dependence of Maryland), the Maryland Mental 
Hygiene Administration’s Annual Conference, and 
the Preventing and Treating Substance Use Disorders 
2014 Conference (sponsored by Community Catalyst).
Professor Deborah Weimer
Professor Weimer has directed the Health Care 
Delivery and HIV/AIDS Clinic at the University of 
Maryland Carey School of Law since 1988. She de-
veloped the HIV Clinic - as it 
is known - as an interdisciplin-
ary effort and has worked with 
medical providers and social 
work staff at the Evelyn Jordan 
Clinic, as well as the Pediatric 
HIV Clinic at the University 
of Maryland Medical System 
(UMMS), for many years. She 
and her students have success-
fully represented clients living 
with HIV in a wide range of 
civil cases since the early years 
of the epidemic. She and her students have also been 
involved in legislative advocacy on the state level 
to improve conditions for individuals and families 
living with HIV illness. The HIV Clinic receives an-
nual grant support from the Maryland Legal Services 
Corporation and the Ryan White Foundation and also 
works closely with the campus-wide JACQUES Initia-
tive which provides medical, social, and legal services 
to individuals living with HIV.
Professor Weimer’s scholarship has focused on the 
value and challenges of interdisciplinary practice. She 
has also advocated for legislative reform to respond to 
the needs of families impacted by HIV. In 2011, she 
co-authored a book chapter titled “Patients and Fami-
lies Living with HIV/AIDS,” that appeared in Poverty, 
Health and Law Readings and Cases for Medical-
Legal Partnership (Elizabeth Tobin Tyler et al. eds.). 
This book is the first of its kind to comprehensively 
describe the role of law and lawyers in helping to ad-
dress and mitigate social disparities in health care in 
Professor Weimer’s newest research focuses 
on the impact that access to legal services 
can have on the health and welfare of 
people living with HIV illness. While an 
interdisciplinary approach to patient care in 
the context of HIV is well accepted, little data 
exists to measure the impact of integrating 
legal services into an interdisciplinary care 
setting. 
Cont. on page 18
Prof. Deborah Weimer
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alumni news
Michael R. Ulrich Named Senior Fellow in Health Law at 
Yale Law School
2011 L&HCP graduate Michael Ulrich was recently named Senior Fellow in 
Health Law and Research Scholar in Law at Yale Law School. Michael was a 
very active member of the L&HCP, acting as President of the Student Health 
Law Organization, participating in the first health law service trip to the Mis-
sissippi Delta, and serving as the Manuscripts Editor for the Journal of Health 
Care Law & Policy. For all his accomplishments at the law school, he earned 
the Public Service Award. Before joining the Yale Law School, he worked 
as a bioethicist in the Division of AIDS at the National Institutes of Health, 
where he reviewed clinical research protocols and grants, and performed ethics 
consultations. Other projects included identifying ethical issues in HIV cure 
research, addressing problems with international specimen sharing, and ways 
to improve tailoring HIV research to vulnerable populations. He also earned 
an M.P.H. from the Harvard School of Public Health in their Law and Public 
Health program. His articles have been published in the Yale Journal of Law & Feminism, Michigan State 
University Journal of Medicine & Law, and American Journal of Bioethics, among others. 
Delora Sanchez Selected for Prestigious Marshall 
Memorial Fellowship 
Delora Sanchez, who graduated from the law school with the Health Law 
Certificate in 2006, was recently selected by the German Marshall Fund of the 
United States to be a Marshall Memorial Fellow. Founded in 1982, the Mar-
shall Memorial Fellowship provides a unique opportunity for emerging leaders 
from the United States and Europe to build an understanding of politics, busi-
ness, innovation, and culture on the other side of the Atlantic. For Fellows, it 
is an intensive learning and networking experience that begins with six months 
of preparations and ends with 24 days of immersion across the Atlantic. The 
German Marshall Fund selects 75 Marshall Memorial Fellows each year from 
35 nations. The fellows are selected from business, government, and civil so-
ciety. Delora is Associate Director of State Affairs at the Johns Hopkins Health 
System Corporation in Baltimore and an active contributor to the L&HCP. She 
will leave on October 16th and spend time in Brussels, Freiburg, Rome, Tirana, 
and Paris. To learn more about the health care system in Europe, she has ar-
ranged to meet with leaders in the health care industry in Belgium, Italy, and Germany. In Tirana, she plans 
to investigate the “concrete mushroom” project which aims to repurpose concrete bunkers that were built 
when Albania was in isolation. According to Sanchez, a Baltimore native, “I am hoping to take some ideas 
and apply them to Baltimore’s over 16,000 vacant buildings.” 
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A Record 48 Graduates Earn the 
Health Law Certificate
At a breakfast reception held on May 14, a record 
48 students were awarded the Health Law Certificate. 
Professor Diane Hoffmann, Director of the Law & 
Health Care Program (L&HCP), and L&HCP faculty 
members presented the certificates to the students and 
spoke about each student individually to the crowd 
of friends and family. This tradition of honoring each 
individual student who gets the certificate has become 
an institution at the law school. The comments—
written by faculty members who get to know the 
students through classes, clinics and externships—
range from laudatory to comical but never fail to 
impress the visiting guests with the incredible breadth 
of activities the students undertake in their three 
years at the law school. The picture that emerged at 
the reception was that of a group of students who 
will become vibrant and valuable members of the 
professional world of health lawyers. In her comments 
at the reception, Hoffmann called the 2014 class of 
health law students "the most dynamic, brilliant, and 
just plain fun group of health law students that I can 
remember in recent history."
This ceremony marked the 17th year that the 
L&HCP at the University of Maryland Carey School 
of Law has been awarding the Health Law Certificate 
to those students who have concentrated their legal 
studies in the area of health law. Each student pursued 
his or her interest in health law in a unique way and 
each student's story is worth recounting but, given 
the limits of space, in this article we focus on five 
certificate students whose various backgrounds and 
career aspirations highlight the breadth of health law 
and its future practitioners. 
Wandaly Esther Fernández
Everyone at the law school knows about Wandaly 
Fernandez. Her contribution to the law school was 
exemplary. In addition to earning the Health Law 
2014 Health Law Certificate Graduates
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Certificate and serving as Manuscripts Editor of the 
Journal of Health Care Law and Policy, Wandaly 
was the President of the 2014 class. She was also the 
only student member of the Dean’s Search Committee 
this year and played a key role in selecting the law 
school’s new dean – Donald Tobin. She participated 
actively in the high powered group of faculty, alumni, 
university officials and community leaders who 
made up the search committee, and her judgments 
were influential in shaping the thinking of the group. 
Wandaly was also a member of the Moot Court 
Board, a semi-finalist in the Myerowitz Moot Court 
Competition, Co-Captain of the National Trial Team, 
Peer Advisor, Admissions Ambassador and Rose 
Zetzer Fellow.  She impressed faculty and staff across 
the law school with her unique leadership skills and 
judgment. Wandaly, who earned her undergraduate 
degree at the University of North Carolina, is now an 
Associate at Epstein Becker Green in Washington DC 
where she joins many other wonderful L&HCP alums 
who remain active and involved in the program as 
competition judges, mentors, and speakers at the law 
school.
the law school at the Loyola University Chicago 
Health Law Transactional Competition. With Brian’s 
help, the team made a presentation at the competition 
that one judge commented was so good it matched 
the degree of difficulty he hoped to meet in his own 
presentations. This deep knowledge of health law was 
fostered by a Masters of Health Administration degree 
Brian obtained from Cornell University. This gave 
Brian a head start in health law that served him very 
well. During law school, he served as a law clerk at 
the Johns Hopkins Health System Legal Department, 
a clerk in the office of U.S. Senator Lindsey Graham 
working on issues relating to implementation of the 
Affordable Care Act, and a health policy intern at 
the American Society of Nuclear Cardiology. Like 
Wandaly, Brian is also a first year Associate at Epstein 
Becker Green where he promises to impress his 
colleagues with a degree of expertise in health law 
rarely seen with recent health law graduates. 
Pari Rashmi Mody 
Pari was one of many students in our program 
whose science background drove their interest in the 
intersection of law and biotechnology. Pari graduated 
from Oberlin College with a BA in Biopsychology 
and a concentration in Cognitive Science in 2006. 
Prior to coming to the law school, she worked as a 
researcher at Johns Hopkins and the University of 
Pennsylvania. Her work in these labs resulted in co-
authoring two scientific articles, “Rats Subjected to 
Chronic-Intermittent Hypoxia (CIH) have Increased 
Density of Noradrenergic Terminals in the Trigeminal 
Sensory (Sp5) and Motor (Mo5) Nuclei” (505 
L&HCP Director Diane Hoffmann, 2014 Graduate Ian 
Clark, Professor Ellen Weber
L&HCP Director Diane Hoffmann addressing 2014 
Health Law Certificate Graduates
Brian Hall 
Brian was a member of the L&HCP who became a 
favorite of the faculty of the program. Professor Kathi 
Hoke called him her “go-to student” in her Public 
Health Law Clinic because of his insight and attention 
to detail. He was also recognized as an incredibly 
knowledgeable member of the team that represented 
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Neuroscience Letters 176–79 (2011)) and “Central but 
not Basolateral Amygdala is Critical for Control of 
Feeding by Aversive Conditioned Cues” (29 Journal 
of Neuroscience 15205-12 (2009)). Pari pursued 
her interest in science and the law at the law school 
and, as a research assistant, was a very important 
part of L&HCP Professor Amanda Pustilnik’s work 
on neuroscience and the law for two years. Upon 
graduation, Pari was named to the Order of the Coif. 
She is now an associate at Squire Patton Boggs LLP. 
James E. Valentine 
James, who graduated in December 2013, was 
(and still is) a critical member of the L&HCP 
notwithstanding the fact that he was an evening 
student with a demanding day job at the FDA. As 
Co-President of SHLO during his second year, 
James helped organize the inaugural Health Law 
Regulatory and Compliance Competition. This 
competition was a great success and has since grown 
into a national competition. James also spearheaded 
an L&HCP conference in partnership with Arnold & 
Porter in Washington, DC, titled Emerging Issues in 
Food and Drug Law: Implementation of FDASIA. 
The conference focused on the Food and Drug 
Administration Safety and Innovation Act (FDASIA) 
and was geared to food and drug law practitioners. 
The conference was a huge success. Now, as a 
recently minted lawyer and Associate at Hyman, 
Phelps, and McNamara PC, James continues to have 
more hours in the day than his peers. He is helping 
to organize the 4th annual regulatory competition that 
he helped start in 2012 and is part of the planning 
committee for the third Emerging Issues in Food and 
Drug Law conference that will focus on the Drug 
Quality and Security Act. The Act was passed by 
Congress to respond to the October 2012 outbreak 
of fungal meningitis that was traced to the poor 
drug compounding practices of the New England 
Compounding Center in Framingham, Massachusetts. 
We are grateful for his continued participation in 
our program and look forward to many years of 
partnership.
Blake Walsh 
Blake arrived at the law school with a BA in History 
of Science and Medicine from Yale University. Her 
undergraduate degree proved to be a perfect entry into 
2014 Graduate Stephanie Noronha with her father and 
Professor Sara Gold
2014 Graduates (from l to r) Stacy Siegel, Melanie Dang, 
Blake Walsh, Wandaly Fernández
2014 Graduates (from l to r) Allan Thorson, Casey Rojas, 
Mallory Montgomery, Leila Ameli-Grillon
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the L&HCP where she thrived. Like many of the other 
students listed in this article, Blake was an integral 
part of the L&HCP as Co-President of the Student 
Health Law Organization in her second year. She was 
Articles Editor of the Maryland Law Review in which 
she published a Note titled “Lefemine v. Wideman: 
Entrenching Judicial Confusion and Beckoning a More 
Streamlined Analysis of First Amendment Violations 
in the Anti-Abortion Protest Context.” Blake was 
also appointed as a law clerk at the world-renowned 
Cleveland Clinic after her second year. Blake’s 
Golnaz Alemousavi
Leila J. Ameli-Grillon
Lucy Brierly Bansal
Angelica Carliner
Travis Franklin Chance
Ian M. Clark
Melanie Dang
Aharon Dinovitz
Kristen Driggers
Wandaly Esther Fernández
Austin Foxwell
Patricia Greenwell
Martin Brian Hall, IV
Mario Hernandez-Gerety
Tereza Hess
Darby Hull
Megan Ix
Michalina Janik
Marta Kikena De Matto
Dana M. Krohn
Johanna Lister
Joanne Micheline Lucas
Nathan Whitmore McCurdy
Pari Rashmi Mody
Mallory Montgomery
Cindy Ann Nguyen
Bradley Nolet
Stephanie B. Noronha
Nkechi N. Nwaogu
Minyoung Park
Chelsea Person
Lauren Patrice Peterson
William Rader
Sara Rigdon
Jorge E. Rodriguez
Casey Rojas
Philip H. Scharper, Jr.
Crystal D. Schroeder
Stacy Lynn Siegel
Eugene Albert Knight Simms
Patrick Stewart
Allan Robert Thorson
Amond Uwadineke
James E. Valentine
Abigail P. Walker
Blake Lauren Walsh
Darren H. Webb
Viola Anna Woolums
2014 health law certificate recipients 
tireless dedication to her work was discussed during 
the May 14 celebration breakfast. L&HCP Professor 
Sara Gold told the attendees that Blake had to spend 
her last Spring Break during law school combing 
through over 1300 pages of medical documentation 
and reorganizing exhibits for an upcoming trial. Her 
sacrifice was rewarded in the end when she was able 
to help her client gain full custody of his younger 
brother. Blake continues to devote her boundless 
energy to health law at Waller Lansden Dortch & 
Davis LLP in Nashville.
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L&HCP Professor Kathi Hoke aka Iron woman
L&HCP Professor Kathi Hoke, whose scholarly accomplishments are de-
tailed in this newsletter, has some equally impressive accomplishments that 
take place outside of the law school. On September 20, Hoke completed the 
Ironman Maryland triathlon. Her finishing time was 13 hours, 41 minutes, 
37 seconds. The race consisted of a 2.4 mile swim in the Choptank River; a 
112 mile bike ride that took her through the Blackwater Wildlife Refuge on 
the Eastern Shore; and a 26.2 mile run through Cambridge, MD. The total 
mileage is 140.6. This was the inaugural Ironman Maryland and Hoke’s first 
full Ironman. She has always been a long distance runner but started doing 
triathlons to celebrate turning 40 in 2007. She started with a sprint distance 
at IronGirl and gradually built up to Olympic distance and Half Iron races 
before tackling the full Ironman. She has done races in Maryland, Pennsylva-
nia, Delaware, New Jersey, New York, and New Hampshire. Hoke said about 
completing the event, “I feel incredibly grateful that my body and mind are 
strong enough to indulge in these adventures and that my family, friends, stu-
dents, and colleagues are supportive of the insanity. I went skydiving in May 
and did Ironman in September; who knows what adventure lies ahead?”
Prof. Kathi Hoke and her son, 
Dominic
Maryland Healthcare Ethics 
Committee Network (MHECN) News
MHECN Grant Award to Study 
MOLST Program
In September the Law & Health Care Program re-
ceived word that the Maryland Office of Health Care 
Quality (OHCQ) had awarded funding to MHECN 
to evaluate the Maryland Medical Orders for Life-
Sustaining Treatment (MOLST) program. MHECN is 
a membership organization for ethics committees at 
health care institutions in Maryland and an initiative 
of the Law & Health Care Program. The Maryland 
MOLST evaluation study will determine whether 
MOLST forms in Maryland health care institutions 
are being used correctly and what impact the MOLST 
program has had on end-of-life care for Marylanders 
since the MOLST program went into effect statewide 
in 2011.
Recognized as a “next generation” advance direc-
tive, MOLST programs have caught the attention of 
communities around the country seeking to improve 
end-of-life care. Currently more than 26 states have 
implemented MOLST-like orders. The MOLST Pro-
gram works by transforming life-sustaining treatment 
preferences into medical orders that can be followed 
by emergency medical technicians, nursing facility 
staff, and other health professionals in times of crisis 
and transition from one setting to the next. However, 
the program’s success is dependent on appropriate 
implementation. Evaluating how the MOLST form is 
being used allows for identifying areas for improve-
ment to achieve the goal of improving end-of-life care. 
 
This evaluation study will address the following ques-
tions:
1. What is the rate of hospital compliance with 
the MOLST-on-discharge obligation?
2. Is there evidence of some process underlying 
completion of the MOLST form?
3. What is the MOLST form completion error 
rate?
4. Is completion of the MOLST form comple-
menting or replacing advance directive com-
pletion? 
Data collection will take place this academic year and 
results should be available by next fall.
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Evolution of Scholarship
Cont. from p. 11
November 10 Conference 
 “Religious, Medical, Ethical and Legal Perspectives on 
End of Life Issues” 
The Law & Health Care Program’s Maryland Healthcare Ethics Committee Network (MHECN) is holding 
a conference on November 10 in conjunction with the Institute for Jewish Continuity and the University of 
Maryland Schools of Medicine, Nursing, Pharmacy, and Social Work. The conference, “Religious, Medical, 
Ethical and Legal Perspectives on End of Life Issues,” will bring together faith representatives, bioethicists, 
ethics committee members, and others to identify religious and ethical questions that arise in the care of patients 
at the end of life and discuss strategies to help patients, family members, and health care providers navigate the 
complexities of end of life decision-making. In addition to a discussion on “Religious Perspectives on ‘God's 
Will,’” conference organizers will facilitate two interprofessional panels that will tackle these complex issues 
from different professional perspectives. The conference is being organized by MHECN Program Coordinator, 
Dr. Anita Tarzian, an Associate Professor at the University of Maryland School of Nursing in the Department of 
Family and Community Health.
a variety of settings. It is designed as both a teaching 
tool and a resource for those interested in medical-le-
gal partnerships. Professor Weimer’s chapter describes 
the relationship between HIV, social determinants of 
health such as poverty, race and sexual orientation, 
and the law. It illustrates how an effective medical 
legal partnership can—and has—addressed the many 
barriers to care faced by people living with HIV. It 
describes legal protections that have been enacted to 
protect individuals and families affected by HIV that 
at the same time can play a role in encouraging people 
to be tested for HIV.
In the last three years, Professor Weimer has initiat-
ed a new clinic to focus particularly on housing issues 
faced by people living with HIV. Substandard housing 
in Baltimore poses a major health risk to individu-
als with chronic health problems including HIV and 
asthma. These issues are described in a recent op-ed 
piece written by Professor Weimer and published by 
the Baltimore Sun in June titled “Justice Eludes Ten-
ants.” 
Professor Weimer’s newest research focuses on the 
impact that access to legal services can have on the 
health and welfare of people living with HIV illness. 
While an interdisciplinary approach to patient care in 
the context of HIV is well accepted, little data exists 
to measure the impact of integrating legal services 
into an interdisciplinary care setting. Effective treat-
ment for HIV is now available but among low income 
people of color, poor health outcomes and deaths from 
HIV-related causes still occur. 
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Abbe Gluck
Professor, Yale Law School
The Challenges of the ACA in the Courts, the Congress and the States: The Legal-Political 
Twists and Turns of the Most Controversial Statute in Modern Times
November 20, 2014
5 pm
Ceremonial Moot Court Room
University of Maryland Francis King Carey
 School of Law
Reception following event
fall 2014 Rome Lecture
 
The Health Law Regulatory & Compliance Competition is a unique and innovative competition that 
challenges law students to navigate through the complex regulatory landscape of health care law, including 
compliance with health care regulations and FDA law. It will be held on Saturday, February 21, 2015, from 
approximately 8:00 a.m. until 3:00 p.m. at the University of Maryland Francis King Carey School of Law in 
Baltimore, MD.
About the Competition: 
The Competition requires teams of 2-3 students to analyze a hypothetical fact pattern involving various 
interactions between health care stakeholders and entities participating in several health care activities that 
necessitate regulatory and compliance oversight. The fact pattern will be given to teams the day of the 
competition, and students will have approximately 1.5 hours to analyze the problem. Teams will then present 
their findings and recommendations to a panel of practicing regulatory and compliance attorneys. The 4th 
Annual Competition will focus on several interactions between various health care stakeholders, including 
hospitals, physicians, drug and device manufacturers, and related third parties. 
 
Call to Compete:
If you would like to have a team from your law school participate in the Competition, you can find additional 
details and information about how to register at www.law.umaryland.edu/health/events/hlrc_competition.html.
4th Annual Health Law Regulatory & Compliance 
Competition: Call to Compete
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Law & HeaLtH Care Program
500 West Baltimore Street
Baltimore, MD 21201
www.law.umaryland.edu/healthlaw
Comments and letters should be 
forwarded to the above address.
